CXCL10 decreases GP73 expression in hepatoma cells at the early stage of hepatitis C virus (HCV) infection

International Journal of Molecular Sciences

Volumn 14, Issue 12, 2013, Pages 24230-24241

  Liu, Yuan ^a   Zou, Ziying ^a   Zhu, Bing ^a   Hu, Zonghai ^a   Zeng, Ping ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

CXCL10; GP73; HCC; Hepatitis C virus; Liver disease

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; GOLGI PROTEIN 73; MEMBRANE PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STAINING; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL PROLIFERATION; CHEMOKINE CXCL10; DOWN-REGULATION; HEK293 CELLS; HEP G2 CELLS; HEPACIVIRUS; HEPATITIS C; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS; PLASMIDS; RNA, MESSENGER; UP-REGULATION; VIRUS REPLICATION;

EID: 84890355676     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141224230     Document Type: Article

References (23)

1. Zhou, Y.; Li, L.; Hu, L.; Peng, T. Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin. Mol. Biol. Rep. 2011, 38, 1457-1462.
2. Kladney, R. D.; Bulla, G. A.; Guo, L.; Mason, A. L.; Tollefson, A. E.; Simon, D. J.; Koutoubi, Z.; Fimmel, C. J. GP73, a novel Golgi-localized protein upregulated by viral infection. Gene 2000, 249, 53-65.
3. Kladney, R. D.; Tollefson, A. E.; Wold, W. S.; Fimmel, C. J. Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain. Virology 2002, 301, 236-246.
4. Marrero, J. A.; Romano, P. R.; Nikolaeva, O.; Steel, L.; Mehta, A.; Fimmel, C. J.; Comunale, M. A.; D'Amelio, A.; Lok, A. S.; Block, T. M. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J. Hepatol. 2005, 43, 1007-1012.
5. Mao, Y.; Yang, H.; Xu, H.; Lu, X.; Sang, X.; Du, S.; Zhao, H.; Chen, W.; Xu, Y.; Chi, T.; et al. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut 2010, 59, 1687-1693.
6. Zhang, F.; Gu, Y.; Li, X.; Wang, W.; He, J.; Peng, T. Up-regulated Golgi phosphoprotein 2 (GOLPH2) expression in lung adenocarcinoma tissue. Clin. Biochem. 2010, 43, 983-991.
7. Fritzsche, F. R.; Riener, M. O.; Dietel, M.; Moch, H.; Jung, K.; Kristiansen, G. GOLPH2 expression in renal cell cancer. BMC Urol. 2008, 8, 15.
8. Chen, M. H.; Jan, Y. H.; Chang, P. M.; Chuang, Y. J.; Yeh, Y. C.; Lei, H. J.; Hsiao, M.; Huang, S. F.; Huang, C. Y.; Chau, G. Y. Expression of GOLM1 correlates with prognosis in human hepatocellular carcinoma. Ann. Surg. Oncol. 2013, 20, 616-624.
9. Sun, Y.; Yang, H.; Mao, Y.; Xu, H.; Zhang, J.; Li, G.; Lu, X.; Sang, X.; Zhao, H.; Zhong, S.; et al. Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival. J. Gastroenterol. Hepatol. 2011, 26, 1207-1212.
10. Chen, L. G.; Wang, H. J.; Yao, H. B.; Guan, T. P.; Wu, F.; He, X. J.; Ma, Y. Y.; Tao, H. Q.; Ye, Z. Y. GP73 is down-regulated in gastric cancer and associated with tumor differentiation. World J. Surg. Oncol. 2013, 11, 132.
11. Yuan, Q.; Chu, C.; Jia, J. Association studies of 19 candidate SNPs with sporadic Alzheimer's disease in the North Chinese Han population. Neurol. Sci. 2012, 33, 1021-1028.
12. Lin, K.; Tang, M.; Han, H.; Guo, Y.; Lin, Y.; Ma, C. Association between the polymorphisms of CALHM1 and GOLPH2 genes and Alzheimer's disease. Psychiatr. Genet. 2010, 20, 190.
13. But, D. Y.; Lai, C. L.; Yuen, M. F. Natural history of hepatitis-related hepatocellular carcinoma. World J. Gastroenterol. 2008, 14, 1652-1656.
14. Kladney, R. D.; Cui, X.; Bulla, G. A.; Brunt, E. M.; Fimmel, C. J. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 2002, 35, 1431-1440.
15. Iftikhar, R.; Kladney, R. D.; Havlioglu, N.; Schmitt-Gräff, A.; Gusmirovic, I.; Solomon, H.; Luxon, B. A.; Bacon, B. R.; Fimmel, C. J. Disease-and cell-specific expression of GP73 in human liver disease. Am. J. Gastroenterol. 2004, 99, 1087-1095.
16. Flint, M.; von Hahn, T.; Zhang, J.; Farquhar, M.; Jones, C. T.; Balfe, P.; Rice, C. M.; McKeating, J. A. Diverse CD81 proteins support hepatitis C virus infection. J. Virol. 2006, 80, 11331-11342.
17. Zhai, Y.; Shen, X. D.; Gao, F.; Zhao, A.; Freitas, M. C.; Lassman, C.; Luster, A. D.; Busuttil, R. W.; Kupiec-Weglinski, J. W. CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology 2008, 47, 207-214.
18. Wei, H.; Li, B.; Zhang, R.; Hao, X.; Huang, Y.; Qiao, Y.; Hou, J.; Li, X.; Li, X. Serum GP73, a marker for evaluating progression in patients with chronic HBV infections. PLoS One 2013, 8, e53862.
19. Liang, H.; Block, T. M.; Wang, M.; Nefsky, B.; Long, R.; Hafner, J.; Mehta, A. S.; Marrero, J.; Gish, R.; Norton, P. A. Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73. Cancer Biomark. 2012, 11, 161-171.
20. Tong, Y.; Zhu, Y.; Xia, X.; Liu, Y.; Feng, Y.; Hua, X.; Chen, Z.; Ding, H.; Gao, L.; Wang, Y. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection. J. Virol. 2011, 85, 2793-2802.
21. Hong, B.; Lee, S. H.; Song, X. T.; Jones, L.; Machida, K.; Huang, X. F.; Chen, S. Y. A super TLR agonist to improve efficacy of dendritic cell vaccine in induction of anti-HCV immunity. PLoS One 2012, 7, e48614.
22. Wakita, T.; Pietschmann, T.; Kato, T.; Date, T.; Miyamoto, M.; Zhao, Z.; Murthy, K.; Habermann, A.; Krausslich, H. G.; Mizokami, M.; et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11, 791-796.
23. Nagpal, M. L.; Davis, J.; Lin, T. Overexpression of CXCL10 in human prostate LNCaP cells activates its receptor (CXCR3) expression and inhibits cell proliferation. Biochim. Biophys. Acta 2006, 1762, 811-818.